FDA authorizes Pfizer COVID vaccine booster for children 5 to 11
Is COVID endemic? This is what well being specialists are saying.
How quickly may we see COVID-19 go from pandemic to endemic? This is what we all know now.
Simply the FAQs, USA TODAY
The Meals and Drug Administration on Tuesday approved Pfizer-BioNTech’s COVID-19 booster shot for kids ages 5 to 11.
The booster dose is out there to youngsters 5 months after finishing their major sequence of two photographs.
The businesses submitted for an emergency use authorization from the FDA final month after a research discovered wholesome youngsters in that age group had a safe and strong immune response to the booster.
Pfizer-BioNTech’s vaccine is the one COVID-19 vaccine approved for youthful youngsters. Kids in that age group get a dose that’s equal to one-third of the dose given to adults.
FDA Commissioner Robert M. Califf stated throughout the omicron wave, extra youngsters are getting sick and being hospitalized.
“Vaccination continues to be the simplest approach to forestall COVID-19 and its extreme penalties, and it’s secure,” Califf stated. “In case your little one is eligible for the Pfizer-BioNTech COVID-19 Vaccine and has not but acquired their major sequence, getting them vaccinated might help defend them from the doubtless extreme penalties that may happen, similar to hospitalization and dying.”
In January, the FDA approved Pfizer-BioNTech’s booster shot for kids ages 12 to fifteen who full their preliminary two-shot sequence.
This implies youthful youngsters who acquired the second of the two-dose sequence earlier than Dec. 17 are actually eligible for a booster.